title: Vitamin D supplementation is associated with stabilization of cardiac autonomic tone in IgA nephropathy.
authors.affiliation: From the Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (M.C.M., B.R.H., D.V.E., D.A.H, T.C.T., S.B.A.); Alberta Kidney Disease Network, Calgary, Alberta, Canada (B.R.H., S.B.A.); Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada (B.R.H., D.E.V., D.Y.S., L.E., S.B.A. D.E.V., D.Y.D.); and Division of Medicine, University College, London, United Kingdom (D.C.W.).
authors.forename: Michelle C
authors.initials: MC
authors.lastname: Mann
authors.affiliation: From the Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (M.C.M., B.R.H., D.V.E., D.A.H, T.C.T., S.B.A.); Alberta Kidney Disease Network, Calgary, Alberta, Canada (B.R.H., S.B.A.); Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada (B.R.H., D.E.V., D.Y.S., L.E., S.B.A. D.E.V., D.Y.D.); and Division of Medicine, University College, London, United Kingdom (D.C.W.).
authors.forename: Brenda R
authors.initials: BR
authors.lastname: Hemmelgarn
authors.affiliation: From the Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (M.C.M., B.R.H., D.V.E., D.A.H, T.C.T., S.B.A.); Alberta Kidney Disease Network, Calgary, Alberta, Canada (B.R.H., S.B.A.); Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada (B.R.H., D.E.V., D.Y.S., L.E., S.B.A. D.E.V., D.Y.D.); and Division of Medicine, University College, London, United Kingdom (D.C.W.).
authors.forename: Derek V
authors.initials: DV
authors.lastname: Exner
authors.affiliation: From the Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (M.C.M., B.R.H., D.V.E., D.A.H, T.C.T., S.B.A.); Alberta Kidney Disease Network, Calgary, Alberta, Canada (B.R.H., S.B.A.); Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada (B.R.H., D.E.V., D.Y.S., L.E., S.B.A. D.E.V., D.Y.D.); and Division of Medicine, University College, London, United Kingdom (D.C.W.).
authors.forename: David A
authors.initials: DA
authors.lastname: Hanley
authors.affiliation: From the Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (M.C.M., B.R.H., D.V.E., D.A.H, T.C.T., S.B.A.); Alberta Kidney Disease Network, Calgary, Alberta, Canada (B.R.H., S.B.A.); Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada (B.R.H., D.E.V., D.Y.S., L.E., S.B.A. D.E.V., D.Y.D.); and Division of Medicine, University College, London, United Kingdom (D.C.W.).
authors.forename: Tanvir C
authors.initials: TC
authors.lastname: Turin
authors.affiliation: From the Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (M.C.M., B.R.H., D.V.E., D.A.H, T.C.T., S.B.A.); Alberta Kidney Disease Network, Calgary, Alberta, Canada (B.R.H., S.B.A.); Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada (B.R.H., D.E.V., D.Y.S., L.E., S.B.A. D.E.V., D.Y.D.); and Division of Medicine, University College, London, United Kingdom (D.C.W.).
authors.forename: David C
authors.initials: DC
authors.lastname: Wheeler
authors.affiliation: From the Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (M.C.M., B.R.H., D.V.E., D.A.H, T.C.T., S.B.A.); Alberta Kidney Disease Network, Calgary, Alberta, Canada (B.R.H., S.B.A.); Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada (B.R.H., D.E.V., D.Y.S., L.E., S.B.A. D.E.V., D.Y.D.); and Division of Medicine, University College, London, United Kingdom (D.C.W.).
authors.forename: Darlene Y
authors.initials: DY
authors.lastname: Sola
authors.affiliation: From the Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (M.C.M., B.R.H., D.V.E., D.A.H, T.C.T., S.B.A.); Alberta Kidney Disease Network, Calgary, Alberta, Canada (B.R.H., S.B.A.); Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada (B.R.H., D.E.V., D.Y.S., L.E., S.B.A. D.E.V., D.Y.D.); and Division of Medicine, University College, London, United Kingdom (D.C.W.).
authors.forename: Linda
authors.initials: L
authors.lastname: Ellis
authors.affiliation: From the Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (M.C.M., B.R.H., D.V.E., D.A.H, T.C.T., S.B.A.); Alberta Kidney Disease Network, Calgary, Alberta, Canada (B.R.H., S.B.A.); Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada (B.R.H., D.E.V., D.Y.S., L.E., S.B.A. D.E.V., D.Y.D.); and Division of Medicine, University College, London, United Kingdom (D.C.W.).
authors.forename: Sofia B
authors.initials: SB
authors.lastname: Ahmed
mesh_terms: D000328:Adult; D001341:Autonomic Nervous System / Q000187:drug effects* / Q000503:physiopathology; D017704:Baroreflex / Q000187:drug effects / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D019587:Dietary Supplements; D005260:Female; D005922:Glomerulonephritis, IGA / Q000150:complications / Q000503:physiopathology*; D006321:Heart / Q000294:innervation* / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D051436:Renal Insufficiency, Chronic / Q000209:etiology / Q000503:physiopathology; D014807:Vitamin D / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000097:blood / Q000494:pharmacology*
chemical_list: D014807:Vitamin D; C097949:1,25-dihydroxyvitamin D